vs
Autonomix Medical, Inc.（AMIX）与Anika Therapeutics, Inc.（ANIK）财务数据对比。点击上方公司名可切换其他公司
Anika Therapeutics, Inc.自由现金流更多（$4.0M vs $-3.0M）
Autonomix Medical是一家专注于心脏电生理领域的医疗科技企业，主要开发用于心律失常诊断与治疗的微创医疗设备，服务北美、欧洲地区的医疗机构与患者，致力于提升心律相关心脏疾病的诊疗效率与效果。
AMIX vs ANIK — 直观对比
营收规模更大
ANIK
是对方的Infinity倍
$0
自由现金流更多
ANIK
多$7.0M
$-3.0M
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $0 | $30.6M |
| 净利润 | $-3.3M | $292.0K |
| 毛利率 | — | 62.6% |
| 营业利润率 | — | 2.1% |
| 净利率 | — | 1.0% |
| 营收同比 | — | 0.0% |
| 净利润同比 | -20.2% | 101.3% |
| 每股收益（稀释后） | — | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMIXANIK
| Q4 25 | $0 | $30.6M | ||
| Q3 25 | $0 | $27.8M | ||
| Q2 25 | $0 | $28.2M | ||
| Q1 25 | $0 | $26.2M | ||
| Q4 24 | $0 | $30.6M | ||
| Q3 24 | $0 | $29.6M | ||
| Q2 24 | $0 | $30.7M | ||
| Q1 24 | — | $29.0M |
净利润AMIXANIK
| Q4 25 | $-3.3M | $292.0K | ||
| Q3 25 | $-7.5M | $-2.3M | ||
| Q2 25 | $-3.3M | $-4.0M | ||
| Q1 25 | $-3.2M | $-4.9M | ||
| Q4 24 | $-2.7M | $-21.9M | ||
| Q3 24 | $-2.8M | $-29.9M | ||
| Q2 24 | $-2.7M | $-88.0K | ||
| Q1 24 | — | $-4.5M |
毛利率AMIXANIK
| Q4 25 | — | 62.6% | ||
| Q3 25 | — | 56.0% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 56.1% | ||
| Q4 24 | — | 56.0% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 66.7% | ||
| Q1 24 | — | 65.4% |
营业利润率AMIXANIK
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | -11.6% | ||
| Q2 25 | — | -14.8% | ||
| Q1 25 | — | -16.4% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -0.3% | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | — | -8.6% |
净利率AMIXANIK
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | -8.4% | ||
| Q2 25 | — | -14.1% | ||
| Q1 25 | — | -18.6% | ||
| Q4 24 | — | -71.4% | ||
| Q3 24 | — | -101.2% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -15.6% |
每股收益（稀释后）AMIXANIK
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.34 | ||
| Q4 24 | — | $-1.49 | ||
| Q3 24 | — | $-2.03 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | — | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $81.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.6M | $143.5M |
| 总资产 | $10.2M | $190.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMIXANIK
| Q4 25 | $9.9M | $81.2M | ||
| Q3 25 | $7.5M | $80.2M | ||
| Q2 25 | $8.6M | $77.1M | ||
| Q1 25 | $9.1M | $75.4M | ||
| Q4 24 | $11.8M | $79.2M | ||
| Q3 24 | $5.2M | $90.7M | ||
| Q2 24 | $6.8M | $96.6M | ||
| Q1 24 | — | $100.7M |
股东权益AMIXANIK
| Q4 25 | $8.6M | $143.5M | ||
| Q3 25 | $6.4M | $146.8M | ||
| Q2 25 | $7.0M | $147.7M | ||
| Q1 25 | $8.1M | $148.4M | ||
| Q4 24 | $9.7M | $154.0M | ||
| Q3 24 | $3.0M | $179.9M | ||
| Q2 24 | $5.3M | $210.3M | ||
| Q1 24 | — | $208.5M |
总资产AMIXANIK
| Q4 25 | $10.2M | $190.3M | ||
| Q3 25 | $7.9M | $189.4M | ||
| Q2 25 | $9.0M | $187.7M | ||
| Q1 25 | $9.8M | $190.6M | ||
| Q4 24 | $12.0M | $202.7M | ||
| Q3 24 | $5.4M | $231.4M | ||
| Q2 24 | $7.1M | $262.7M | ||
| Q1 24 | — | $263.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $4.6M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | $4.0M |
| 自由现金流率自由现金流/营收 | — | 13.0% |
| 资本支出强度资本支出/营收 | — | 2.1% |
| 现金转化率经营现金流/净利润 | — | 15.88× |
| 过去12个月自由现金流最近4个季度 | — | $4.4M |
8季度趋势，按日历期对齐
经营现金流AMIXANIK
| Q4 25 | $-3.0M | $4.6M | ||
| Q3 25 | $-3.8M | $6.9M | ||
| Q2 25 | $-2.6M | $-189.0K | ||
| Q1 25 | $-2.6M | $-130.0K | ||
| Q4 24 | $-2.3M | $1.6M | ||
| Q3 24 | $-1.6M | $5.0M | ||
| Q2 24 | $-1.9M | $-1.1M | ||
| Q1 24 | — | $-126.0K |
自由现金流AMIXANIK
| Q4 25 | $-3.0M | $4.0M | ||
| Q3 25 | — | $5.0M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | $-2.3M | $275.0K | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | $-1.9M | $-4.5M | ||
| Q1 24 | — | $-1.9M |
自由现金流率AMIXANIK
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | — | -5.9% | ||
| Q1 25 | — | -11.3% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 12.9% | ||
| Q2 24 | — | -14.6% | ||
| Q1 24 | — | -6.7% |
资本支出强度AMIXANIK
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 6.2% |
现金转化率AMIXANIK
| Q4 25 | — | 15.88× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMIX
暂无分部数据
ANIK
| OEM Channel | $17.3M | 57% |
| Commercial Channel | $13.3M | 43% |
